AstraZeneca PLC
LSE:AZN
AstraZeneca PLC
Cash Paid for Dividends
AstraZeneca PLC
Cash Paid for Dividends Peer Comparison
Competitive Cash Paid for Dividends Analysis
Latest Figures & CAGR of Competitors
Company | Cash Paid for Dividends | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
AstraZeneca PLC
LSE:AZN
|
Cash Paid for Dividends
-$4.5B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-2%
|
|
GlaxoSmithKline PLC
LSE:GSK
|
Cash Paid for Dividends
-£2.3B
|
CAGR 3-Years
17%
|
CAGR 5-Years
10%
|
CAGR 10-Years
5%
|
|
Verona Pharma PLC
NASDAQ:VRNA
|
Cash Paid for Dividends
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Indivior PLC
LSE:INDV
|
Cash Paid for Dividends
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Hikma Pharmaceuticals PLC
LSE:HIK
|
Cash Paid for Dividends
-$137m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-13%
|
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
Cash Paid for Dividends
-£51.7m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
-17%
|
See Also
What is AstraZeneca PLC's Cash Paid for Dividends?
Cash Paid for Dividends
-4.5B
USD
Based on the financial report for Mar 31, 2024, AstraZeneca PLC's Cash Paid for Dividends amounts to -4.5B USD.
What is AstraZeneca PLC's Cash Paid for Dividends growth rate?
Cash Paid for Dividends CAGR 10Y
-2%
Over the last year, the Cash Paid for Dividends growth was -1%. The average annual Cash Paid for Dividends growth rates for AstraZeneca PLC have been -7% over the past three years , -5% over the past five years , and -2% over the past ten years .